.
Angewandte
Communications
duplex showed that the 2’,4’-bridge of a-l-LNA lies inside the
major groove and also mapped the orientation of torsion
angle g for the modified nucleotide within the oligonucleotide
duplex.[9] Using the NMR structure of the modified duplex as
a starting point, we previously introduced (R)-configured
methyl groups at the 5’- and 6’-positions on the a-l-LNA
scaffold to give analogues 7 and 8, respectively.[10] Evaluation
of oligonucleotides modified with 7 or 8 in thermal denatura-
tion experiments revealed that both of these analogues
display a-l-LNA-like affinity for RNA. Accordingly, we
hypothesized that tethering these methyl groups together,
forming a six-membered ring between the 5’- and 6’-positions
of the a-l-LNA nucleoside monomer (that is 2’,4’-5’,6’-bis-
constrained-a-l-tricyclic nucleic acid (9) or 2’,4’-5’,6’-bc-a-l-
TriNA), would further improve affinity for RNA by restrict-
ing rotation around angle g.
While considering various approaches to 9, we were aware
that stereocontrolled formation of the 2’,4’-anhydro bridge
(that is the 1,4-dioxa[2.2.1]heptane motif) in 9 would present
a major synthetic challenge, and thus planned the route
accordingly. Oxidation of 10, readily available from diace-
tone-d-glucose,[11] afforded aldehyde 11, which was subjected
to a Sakurai allylation reaction[12] to give 12 after pivaloyla-
tion and removal of the TBS protecting group (Scheme 2).
Oxidation of the a-configured hydroxymethyl group to the
corresponding aldehyde and subsequent treatment with
vinylmagnesium bromide afforded a 1:1 mixture of allylic
alcohols 13, which were converted into the spirocyclic cyclo-
hexene using a ring-closing metathesis reaction in the
presence of Grubbsꢀ second-generation catalyst and in
excellent overall yield. An oxidation–reduction sequence
afforded enantiopure spirocycle 14, which was subjected to
catalytic hydrogenation and protected as the 2-naphthyl-
methyl (Nap) ether to give 15. A three-step sequence
culminating with a Vorbrꢁggen glycosylation afforded orthog-
onally O-protected spirocyclic thymidyl nucleoside 16 in 80%
overall yield.[13] Chemoselective ester hydrolysis, followed by
mesylation of the 2’-OH group gave mesylate 17.
In the original synthetic proposal for 9, we envisaged that
exposing the 2’,6’-dimesylate analogue of 17 to hydroxide
would facilitate formation of the 2’,4’-anhydro bridge in
a single synthetic step, however, formation of the 2,6’-
anhydronucleoside prevailed instead. These initial attempts
at constructing the 2’,4’-anhydro bridge of 9 indicated that it
was essential to protect the free nitrogen atom of 17 prior to
cycloetherification.
Accordingly,
1,8-diazabicyclo-
[5.4.0]undec-7-ene (DBU)-induced formation of the 2,2’-
Scheme 2. Synthesis of thymidyl spironucleoside 23.[14] Reagents and
conditions: a) pyridinium chlorochromate (PCC), NaOAc, 4 ꢂ molec-
ular sieves (MS), CH2Cl2, 08C to RT, 5 h; b) BF3·OEt2, allyltrimethylsi-
lane, CH2Cl2, À788C, 3 h, 78% over two steps; c) pivaloyl chloride
(PivCl), 4-dimethylaminopyridine (DMAP), pyridine, 1008C, 24 h, 92%;
d) tetra-n-butylammonium fluoride (TBAF), THF, RT, 3 h, 88%; e) PCC,
NaOAc, 4 ꢂ MS, CH2Cl2, 08C to RT, 3 h, 81%; f) vinylmagnesium
bromide, Et2O, 08C, 30 min., 95% (dr=1:1); g) Grubbs II (1 mol%),
CH2Cl2, 408C, 1 h, 93%; h) PCC, NaOAc, 4 ꢂ MS, CH2Cl2, 08C to RT,
4 h; i) CeCl3·7H2O, NaBH4, MeOH, 08C, 20 min., 85% over two steps;
j) H2, 10% Pd/C, THF, RT, 4 h, 96%; k) NapBr, NaH, tetra-n-butylam-
monium iodide (TBAI), tetrahydrofuran/N,N-dimethylformamide
(THF/DMF; 1:1), 08C to RT, 2.5 h, 83%; l) 80% AcOH, 808C, 24 h;
m) Ac2O, DMAP, pyridine, 08C to RT, 15 h, 95% over two steps;
n) thymine, N,O-bis(trimethylsilyl)acetamide (BSA), 1,2-dichloro-
ethane, 808C, 1 h; then trimethylsilyl trifluoromethanesulfonate
(TMSOTf), 08C to 508C, 19 h, 84%; o) K2CO3, MeOH, RT, 15 h;
p) methanesulfonyl chloride (MsCl), pyridine, 08C to RT, 12 h, 86%
over two steps. q) DBU, MeCN, 808C, 12 h; r) NaOH, EtOH/H2O
(1:1), 908C, 2 h; s) DBU, BOMCl, DMF, 08C, 1 h, 65% over three
steps; t) Tf2O, pyridine, CH2Cl2, 08C, 30 min.; u) NaNH2, DMF, 558C,
15 min., 52% over two steps; v) 2,3-dichloro-5,6-dicyanobenzoquinone
(DDQ), CH2Cl2/H2O (9:1), RT, 1 h, 92%; w) levulinic acid (LevOH), 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC·HCl), iPr2NEt,
DMAP, CH2Cl2., RT, 10 h, 84%; x) H2, Pd(OH)2/C, MeOH/EtOAc (1:1),
RT, 3 d; then iPr2NEt, RT, 1 h, 95%; y) NC(CH2)2OP(NiPr2)2, 1H-
tetrazole, N-methylimidazole, DMF, RT, 6 h, 55%.
2
ꢀ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2012, 51, 1 – 5
These are not the final page numbers!